Standard BioTools receives Nasdaq deficiency notice for failing $1 minimum bid price

Filed July 24, 2026 · Period ending July 22, 2026 · ~1 min read

Key Changes

• high

  Nasdaq notified Standard BioTools on July 22 that its stock failed to maintain the required $1.00 minimum bid price for 30 consecutive business days, triggering a compliance review.

  Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule verify on EDGAR →
• high

  The company has 180 days (until January 19, 2027) to regain compliance by closing above $1.00 for at least 10 consecutive business days; if unsuccessful, may transfer to Nasdaq Capital Market for an additional 180-day period.

  Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule verify on EDGAR →
• medium

  Stock continues to trade normally on Nasdaq Global Select Market under ticker LAB during the compliance period with no impact on business operations or SEC reporting requirements.

  Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule verify on EDGAR →